{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.ai-analytics.org/api/v1/fda/warning-letters/check?name=Signature%20Formulations%2C%20LLC","name":"Signature Formulations, LLC","_source":{"data_provider":"AI Analytics","data_provider_url":"https://api.ai-analytics.org","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-09-23T22:39:17.389Z"},"count":1,"matches":[{"id":"6f0ccf528b8efdcd","posted_date":"2026-02-10","letter_issue_date":"2026-01-21","company_name":"Signature Formulations, LLC","issuing_office":"Center for Drug Evaluation and Research (CDER)","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.ai-analytics.org/fda-warning/6f0ccf528b8efdcd"}]}